# Early Phase Clinical Trial Units

> **NIH NIH N01** · ALLUCENT GOVERNMENT SERVICES (US) LLC · 2022 · $131,595

## Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases, and can carry out all aspects of interventional clinical trial implementation.

## Key facts

- **NIH application ID:** 10655853
- **Project number:** 75N93022D00015-0-759302200001-1
- **Recipient organization:** ALLUCENT GOVERNMENT SERVICES (US) LLC
- **Principal Investigator:** KELLY MCKEE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $131,595
- **Award type:** —
- **Project period:** 2022-01-14 → 2023-01-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10655853

## Citation

> US National Institutes of Health, RePORTER application 10655853, Early Phase Clinical Trial Units (75N93022D00015-0-759302200001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10655853. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*